The global virtual clinical trials market is projected to grow at a compound annual growth rate (CAGR) of 4.86% from 2024 to 2032. Key factors contributing to this growth include the increasing demand for patient-centric approaches, advancements in technology such as telemedicine and wearables, the impact of the COVID-19 pandemic, a focus on real-world evidence, and collaboration amon... https://www.imarcgroup.com/virtual-clinical-trials-market